Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
Immune checkpoint inhibitors (ICI) are the standard of care for various malignancies and have been associated with a wide spectrum of complications that are phenotypically akin to primary autoimmune diseases. While the literature on these toxicities is growing, there is a paucity of data regarding I...
Saved in:
Main Authors: | Michael Macklin (Author), Sudeep Yadav (Author), Reem Jan (Author), Pankti Reid (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
by: Maria Maddalena Nicoletti, et al.
Published: (2023) -
Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016) -
Keloids in scleroderma-keloidal scleroderma: A unique entity
by: Sumit Sen, et al.
Published: (2013) -
Finger Printlessness in Scleroderma
by: Milad HOSSEINIALHASHEMI, et al.
Published: (2016) -
Localized scleroderma in children
by: Katarzyna A. Wolska-Gawron, et al.
Published: (2020)